-
Neuroprotective effect of Boswellia dalzielii extracts in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
-
Neuroprotective effects of estradiol and progesterone in brain of different age groups of naturally menopausal rats.: A therapeutic potential drug for Parkinson’s disease
-
Neuroprotective effects of Ibudilast, a Phosphodiesterase IV inhibitor in mouse model of Parkinson’s disease
-
Neuroprotective trial design methodology for Parkinson’s: a scoping review
-
Neuropsychological correlates of Cognitive fluctuations in dementia with Lewy bodies
-
Neuropsychological evaluation of cerebellar cognitive function in a series of patients with genetically confirmed CANVAS.
-
Neurovascular and immune determinants of selective vulnerability of dopaminergic neurons in Parkinson’s Disease
-
New-onset gait problems after bilateral STN-DBS for Parkinson’s disease: A systematic review
-
New-onset Parkinsonism after Covid-19: is there a link? A 2022 report of clinical cases
-
Newly identified cases of parkinsonism and prodromal PD in a remote LRRK2 G2019S cohort
- « Previous Page
- 1
- …
- 96
- 97
- 98
- 99
- 100
- …
- 153
- Next Page »